clinical 1,914 words KG: UB-311 Alzheimer's Vaccination Trial 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:published
Contents

UB-311 Alzheimer's Vaccination Trial

Knowledge Graph

Related Hypotheses (16)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE Isoform Conversion Therapy
Score: 0.44
Phase-Separated Organelle Targeting
Score: 0.52

Related Analyses (8)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40

See Also (15)

vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 4 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 4 hypotheses

Knowledge Graph (1 edges)

UB-311 Alzheimer's Vaccination Trial references APOE